Steroid-toxicity insights

The Global Initiative of Asthma (GINA) estimates that more than 17 million patients worldwide have severe uncontrolled asthma. The condition is defined as asthma that is uncontrolled despite the use ...

During 2023, the Steritas team had the opportunity to speak with a range of inspiring clinical research leaders who shared their expertise with us and our colleagues. Every conversation underscored ...

Ever since the introduction of the Steritas Glucocorticoid Toxicity Index (GTI) in 2017, there has been a remarkable surge in the number of clinicians and clinical researchers using Steritas's ...

When the stakes involve patient outcomes and the credibility of clinical trials in the medical, health and pharmaceutical sectors, maintaining data accuracy, integrity and privacy is essential. In ...

Exciting results from an open-label Phase 2 pilot trial published in Lancet Rheumatology[1] suggest that obexelimab, a potential new treatment for IgG4-related disease (IgG4-RD), may become an ...